New Delhi: The Centre has informed the Delhi High Court that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for the age group of 12 to 18. The affidavit filed by under secretary, Department of Health and Family Welfare, said: "It is submitted that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for between the age group of 12 to 18 and subject to the statutory permissions, the same may be available in near future for children of the age group of 12 to 18 years of age".
The affidavit added that May 1 onwards under the liberalized pricing and accelerated national Covid vaccination strategy, all citizens above the age of 18 years including parents of children who are residing ion Delhi are already eligible for Covid-19 vaccination. The Centre said the vaccination is its top most priority and all efforts are being made to achieve "an objective of 100 percent vaccination in the shortest time possible keeping the available resources in mind and availability of vaccine doses into consideration".
Also Read:Zydus gets nod for clinical trials of antibodies cocktail to treat Covid: Sources
The Centre filed this affidavit in response to the plea, filed by Tia Gupta through advocate Bihu Sharma demanding for immediate vaccination of children between the ages of 12-17 in the city, and also prioritizing of vaccination for parents having children up to 17 years of age. In June last week, the Centre had informed the Supreme Court that Zydus Cadila, has concluded its clinical trials for the 12 to 18 age group, and the vaccine may be available in near future, subject to the statutory permissions.